Female PCPs Have Equal/Better Quality Outcomes Than Male PCPs

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 20, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, May 20, 2025 -- Female primary care physicians (PCPs) in value-based payment models have equal or better quality outcomes and higher earning than their male counterparts, according to a research letter published online May 16 in JAMA Health Forum to coincide with the annual meeting of the Society of General Internal Medicine, held from May 14 to 17 in Hollywood, Florida.

Ishani Ganguli, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues examined gender differences in reimbursed earnings and quality among PCPs participating in full risk-sharing arrangements with Medicare Advantage (MA) plans, which enroll most Medicare-eligible adults. The study included 2,022 patient-level MA claims and Medicare Star quality data from 13 payers. Physician gender differences in per-patient earnings estimated as fee-for-service payment and as a value-based payment were examined as the primary outcomes.

Data were included for 872 PCPs (40.4 percent women) working in 15 practice groups in seven states, with 223,810 patients. The researchers found that male and female PCPs had similar specialties and degrees. Fewer MA enrollees and higher proportions of female patients were seen for female PCPs' panels. Female PCPs' patients had better hemoglobin A1c control, eye examination receipt, and composite quality scores when comparing male and female PCPs in the same practice groups, as well as fewer emergency department visits and hospitalizations; worse provider rating scores were seen for women. Female PCPs had similar and more earnings to male PCPs via fee-for-service and value-based payment, respectively.

"These results support the possibility that growing use of value-based payment might improve the gender wage gap and better reward high-quality care," the authors write.

One author disclosed ties to F-Prime; several authors disclosed ties to agilon.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-21 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords